| Gene symbol | PDCD1 | Synonyms | CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2q37.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | programmed cell death 1 | ||||
| GTO ID | GTC1635 |
| Trial ID | NCT02867332 |
| Disease | Metastatic Renal Cell Carcinoma |
| Altered gene | PDCD1 |
| Therapeutic/Target gene | Target gene |
| Therapy | Gene editing |
| Treatment | PD-1 Knockout T cells |
| Phase | Phase1 |
| Recruitment status | Withdrawn |
| Title | A Dose-escalation Phase I Trial of PD-1 Knockout Engineered T Cells for the Treatment of Metastatic Renal Cell Carcinoma |
| Year | 2016 |
| Country | China |
| Company sponsor | Peking University |
| Other ID(s) | 11007965940 |
| Cohort 1 | |||||||||||||
|
|||||||||||||